PUBLIC CONTRACT · 2025
4180160/2025-aq. CENTRALT1268 trastuzumab emtansina 100 mg
- Contract value
- €10,250.66
- Signed on
- 12 March 2025
- Procedure
- Ao abrigo de acordo-quadro (art.º 258.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 11412250PUBLISHED SUBJECT
4180160/2025-AQ. CENTRALT1268 TRASTUZUMAB EMTANSINA 100 MG
Parties involved
- Place of performance
- Portugal, Setúbal, Barreiro
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- ROCHE FARMACÊUTICA QUIMICA, LDA. · Tax ID 500233810
Values and timeline
- Contract price
- €10,250.66
- Procedure base price
- €10,250.66
- Total effective price
- €10,250.66
- Publication date
- 9 May 2025
- Award date
- 12 March 2025
- Signing date
- 12 March 2025
- Performance period
- 294 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 258.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 258.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL 111-B/2017 ) e DLR no 34/2008/M, de 14.08 (DLR n.º 6/2018/M)
- Framework agreement
- 1108/2024 - Convite à apresentação de propostas ao abrigo do(s) acordo(s)-quadro 671/2023 - Medicamentos Diversos e 491/2023 - Medicamentos do foro oncológico e imunomoduladores para aquisição de medicamentos
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7602881
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.